TESTOSTERONE IS A KEY RISK FACTOR FOR NONALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS IN YOUNG PRE-MENOPAUSAL WOMEN WITH FATTY LIVER

被引：0

作者：

Sarkar, Monika ^{[1
]}

Suzuki, Ayako ^{[2
]}

Abdelmalek, Manal F. ^{[3
]}

Bass, Nathan M. ^{[1
]}

Wilson, Laura ^{[4
]}

Yates, Katherine ^{[5
]}

Cedars, Marcelle ^{[6
]}

Gill, Ryan ^{[7
]}

Terrault, Norah ^{[8
]}

机构：

[1] UCSF, Med GI Hepatol, San Francisco, CA USA

[2] Duke Univ, Gastroenterol, Durham VA Med Ctr, Durham, NC 27706 USA

[3] Duke Univ, Gastroenterol, Durham, NC 27706 USA

[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA

[5] Johns Hopkins, Baltimore, MD USA

[6] Univ Calif San Francisco, Obstet & Gynecol, San Francisco, CA 94143 USA

[7] Univ Calif San Francisco, Pathol, San Francisco, CA 94143 USA

[8] Univ Southern Calif, Div Gastrointestinal & Liver Dis, Los Angeles, CA USA

来源：

HEPATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1638

引用

页码：996 / 997

页数：2

共 50 条

[41] Nonalcoholic Fatty Liver Disease as a Risk Factor for Prolonged Corrected QT Interval in Apparently Healthy Korean Women [J].

Chung, Tae-Ha ;

Shim, Jae-Yong ;

Lee, Yong-Jae .

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020, 29 (01) :59-64

[42] Nonalcoholic Fatty Liver Disease May Be an Independent, Modifiable Risk Factor for Young-Onset Digestive Tract Cancers [J].

Wang, Gang ;

Zhuo, Ning ;

Liu, Zhichun .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (32) :5070-5071

[43] METABOLIC ABNORMALITIES AND ATHEROSCLEROSIS: NASH AND LIVER ABNORMALITIES. CARDIOMETABOLIC RISK FACTORS IN YOUNG V/S MIDDLE-AGED PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE [J].

Ivanova, R. ;

Marinova, C. ;

Alexiev, A. ;

Mateva, L. .

ATHEROSCLEROSIS, 2016, 252 :E154-E154

[44] Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study [J].

Lemoine, Maud ;

Assoumou, Lambert ;

De Wit, Stephane ;

Girard, Pierre-Marie ;

Valantin, Marc Antoine ;

Katlama, Christine ;

Necsoi, Coca ;

Campa, Pauline ;

Huefner, Anja D. ;

Wiesch, Julian Schulze Zur ;

Rougier, Hayette ;

Bastard, Jean-Philippe ;

Stocker, Hartmut ;

Mauss, Stefan ;

Serfaty, Lawrence ;

Ratziu, Vlad ;

Menu, Yves ;

Schlue, Jerome ;

Behrens, Georg ;

Bedossa, Pierre ;

Capeau, Jacqueline ;

Ingiliz, Patrick ;

Costagliola, Dominique .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 80 (04) :E86-E94

[45] The Il1β+3953 C>T Polymorphism Minor Allele is Associated with a Higher NAFLD Activity Score, Presence of Nonalcoholic Steatohepatitis and is an Independent Risk Factor for Advanced Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease [J].

Nelson, James E. ;

Yeh, Matthew M. ;

Kowdley, Kris V. .

HEPATOLOGY, 2012, 56 :883A-883A

[46] Nonalcoholic steatohepatitis (NASH) or high probability of fibrosis based on noninvasive marker panels (APRI, FIB-4, NFS) at disease presentation is associated with increased all-cause mortality in patients with nonalcoholic fatty liver disease (NAFLD) [J].

Ha, Nghiem B. ;

Le, Richard H. ;

Trinh, Sam ;

Nguyen, Michael D. ;

Yip, Benjamin ;

Hoang, Joseph K. ;

Nguyen, Mindie H. .

HEPATOLOGY, 2016, 64 :592A-592A

[47] LDL:HDL Ratio as a Risk Factor for Non-Alcoholic Steatohepatitis (NASH) in Non-Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients [J].

Mitchell, Brittany ;

Aggarwal, Manik ;

McCullough, Arthur .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 :S544-S545

[48] THE IL1β+3953 C>T POLYMORPHISM MINOR ALLELE IS ASSOCIATED WITH A HIGHER NAFLD ACTIVITY SCORE, LESS PARENCHYMAL IRON, THE PRESENCE OF NONALCOHOLIC STEATOHEPATITIS AND IS AN INDEPENDENT RISK FACTOR FOR ADVANCED FIBROSIS IN SUBJECTS WITH NONALCOHOLIC FATTY [J].

Nelson, James ;

Yeh, Matthew ;

Kowdley, Kris .

AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) :E234-E234

[49] COMBINATION OF AN ACETYL-CoA CARBOXYLASE (ACC) INHIBITOR AND FIBROBLAST GROWTH FACTOR 19 (FGF19) REDUCED TISSUE TRIGLYCERIDE CONTENT AND FIBROSIS IN A 3D HUMAN LIVER MICROTISSUE MODEL OF NONALCOHOLIC STEATOHEPATITIS (NASH) [J].

Tsai, Wen-Wei ;

Bieri, Manuela ;

Grepper, Sue ;

Thoma, Eva ;

Trevaskis, James L. .

HEPATOLOGY, 2021, 74 :1133A-1133A

[50] Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE) [J].

Eskridge, Wayne ;

Vierling, John M. ;

Gosbee, Wayne ;

Wan, Gabriella A. ;

May-Linh Hyunh ;

Chang, Henry E. .

PLOS ONE, 2021, 16 (11)

← 1 2 3 4 5 →